Literature DB >> 17401153

Characterization of 5-HT3 receptor mutations identified in schizophrenic patients.

Andrew J Thompson1, Nora L Sullivan, Sarah C R Lummis.   

Abstract

The 5-HT3 receptor is a member of the Cys-loop family of ligand-gated ion channels, proteins that have been implicated in the pathology of several neurological disorders. In this study, we examine two mutations (R344H and P391R) that have been previously identified in individuals diagnosed with schizophrenia. These mutations are located in the M3-M4 loop of the 5-HT3 receptor and their occurrence presents the possibility that they contribute toward the etiology of this disorder. Radioligand binding with the 5-HT receptor antagonist, [3H]granisetron, revealed no significant difference in receptor affinity or density between mutant and wild-type receptors when expressed in HEK293 cells. However, comparison of EC50 values using whole-cell patch clamp for wild-type (1.68 microM +/- 0.01, n = 38), R344H (1.70 microM +/- 0.02, n = 18), and P391R (2.73 microM +/- 0.01, n = 8) receptors revealed a significant increase in the EC50 of the P391R mutant. Analysis of Hill co-efficients, and activation and desensitization rate constants showed no significant difference between wild-type and mutant receptors. These data suggest that the P391R, but not the R344H, mutation may play a role in the pathology of schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17401153      PMCID: PMC2649375          DOI: 10.1385/JMN:30:3:273

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  35 in total

1.  Phosphorylation of the 5-hydroxytryptamine3 (5-HT3) receptor expressed in HEK293 cells.

Authors:  S Lankiewicz; M B Hüser; R Heumann; H Hatt; G Gisselmann
Journal:  Receptors Channels       Date:  2000

2.  The primer generator: a program that facilitates the selection of oligonucleotides for site-directed mutagenesis.

Authors:  A Turchin; J F Lawler
Journal:  Biotechniques       Date:  1999-04       Impact factor: 1.993

3.  A BIOCHEMICAL AND PHARMACOLOGICAL SUGGESTION ABOUT CERTAIN MENTAL DISORDERS.

Authors:  D W Woolley; E Shaw
Journal:  Proc Natl Acad Sci U S A       Date:  1954-04       Impact factor: 11.205

4.  A single ring of charged amino acids at one end of the pore can control ion selectivity in the 5-HT3 receptor.

Authors:  Andrew J Thompson; Sarah C R Lummis
Journal:  Br J Pharmacol       Date:  2003-08-11       Impact factor: 8.739

5.  Serotonin facilitates GABAergic transmission in the CA1 region of rat hippocampus in vitro.

Authors:  N Ropert; N Guy
Journal:  J Physiol       Date:  1991-09       Impact factor: 5.182

6.  Direct inhibition of 5-hydroxytryptamine3 receptors by antagonists of L-type Ca2+ channels.

Authors:  A C Hargreaves; M J Gunthorpe; C W Taylor; S C Lummis
Journal:  Mol Pharmacol       Date:  1996-11       Impact factor: 4.436

7.  Enhancement of 5-hydroxytryptamine3A receptor function by phorbol 12-myristate, 13-acetate is mediated by protein kinase C and tyrosine kinase activity.

Authors:  Steven J Coultrap; Tina K Machu
Journal:  Receptors Channels       Date:  2002

8.  Novel GLRA1 missense mutation (P250T) in dominant hyperekplexia defines an intracellular determinant of glycine receptor channel gating.

Authors:  B Saul; T Kuner; D Sobetzko; W Brune; F Hanefeld; H M Meinck; C M Becker
Journal:  J Neurosci       Date:  1999-02-01       Impact factor: 6.167

Review 9.  Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia.

Authors:  H Y Meltzer
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

10.  Modulation of 5-HT3 receptor-mediated response and trafficking by activation of protein kinase C.

Authors:  Hui Sun; Xian-Qun Hu; Edgar M Moradel; Forrest F Weight; Li Zhang
Journal:  J Biol Chem       Date:  2003-06-05       Impact factor: 5.157

View more
  9 in total

1.  Delineating the Site of Interaction of the 5-HT3A Receptor with the Chaperone Protein RIC-3.

Authors:  Elham Pirayesh; Antonia G Stuebler; Akash Pandhare; Michaela Jansen
Journal:  Biophys J       Date:  2019-11-28       Impact factor: 4.033

Review 2.  The 5-HT3 receptor--the relationship between structure and function.

Authors:  Nicholas M Barnes; Tim G Hales; Sarah C R Lummis; John A Peters
Journal:  Neuropharmacology       Date:  2008-08-12       Impact factor: 5.250

Review 3.  3B but which 3B and that's just one of the questions: the heterogeneity of human 5-HT3 receptors.

Authors:  Anders A Jensen; Paul A Davies; Hans Bräuner-Osborne; Karen Krzywkowski
Journal:  Trends Pharmacol Sci       Date:  2008-09       Impact factor: 14.819

4.  5-HT3a Receptors Modulate Hippocampal Gamma Oscillations by Regulating Synchrony of Parvalbumin-Positive Interneurons.

Authors:  Ying Huang; Kristopher Yoon; Ho Ko; Song Jiao; Wataru Ito; Jian-Young Wu; Wing-Ho Yung; Bai Lu; Alexei Morozov
Journal:  Cereb Cortex       Date:  2014-09-21       Impact factor: 5.357

5.  Lamotrigine, an antiepileptic drug, inhibits 5-HT3 receptor currents in NCB-20 neuroblastoma cells.

Authors:  Ki Jung Kim; Seung Hyun Jeun; Ki-Wug Sung
Journal:  Korean J Physiol Pharmacol       Date:  2017-02-21       Impact factor: 2.016

6.  Genetic polymorphisms and their association with brain and behavioural measures in heterogeneous stock mice.

Authors:  Magdalena Janecka; Sarah J Marzi; Michael J Parsons; Lin Liu; Jose L Paya-Cano; Rebecca G Smith; Cathy Fernandes; Leonard C Schalkwyk
Journal:  Sci Rep       Date:  2017-02-01       Impact factor: 4.379

7.  Selective serotonin reuptake inhibitor escitalopram inhibits 5-HT3 receptor currents in NCB-20 cells.

Authors:  Yong Soo Park; Ki-Wug Sung
Journal:  Korean J Physiol Pharmacol       Date:  2019-10-24       Impact factor: 2.016

8.  The serotonin 5-HT3 receptor: a novel neurodevelopmental target.

Authors:  Mareen Engel; Marten P Smidt; Johannes A van Hooft
Journal:  Front Cell Neurosci       Date:  2013-05-27       Impact factor: 5.505

9.  Identification of a domain which affects kinetics and antagonistic potency of clozapine at 5-HT3 receptors.

Authors:  Gerhard Rammes; Christine Hosp; Brigitte Eisensamer; Sascha Tanasic; Caroline Nothdurfter; Walter Zieglgänsberger; Rainer Rupprecht
Journal:  PLoS One       Date:  2009-08-21       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.